Latest filing published 02 Mar 2023 for AbbVie Inc., €1.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +31.5%Entry US$84.69 · Close at T+365 US$111.39
- +64.2%Entry US$64.50 · Close at T+365 US$105.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brian L. Durkin: trading record in brief
In March 2020, Brian L. Durkin made three purchases at AbbVie Inc.: EUR 136,168 on March 18, then EUR 100,353 and EUR 50,669 on March 20. The record counts 5 purchases worth EUR 384,307, median EUR 50,669, and 4 sales worth EUR 3,945,079, median EUR 1,151,793. Purchases make up 56% of open-market trades. The largest sales date from March 9, 2022 (EUR 1,607,983 and EUR 956,027) and December 20, 2021 (EUR 1,347,559).
The 38 filings, published from February 22, 2019 to March 2, 2023, concern this single issuer, with the title VP, Controller. They include 27 share grants and 2 option exercises. Annual volume reaches 11 filings in 2020, its highest year, then 7 in 2019 and 2021, 8 in 2022 and 5 in 2023. No filing falls in the last twelve months.
They appear a median of 4 days after the trade, across 37 dated filings. At AbbVie, Edward J. Rapp has 5 open-market trades within 30 days of those of Durkin, Elaine K. Sorg, Jeffrey Ryan Stewart and Timothy J. Richmond 3 each, all in the same direction.
Companies and markets linked to Brian L. Durkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,182 shares@ US$154.2841.9% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-003853:0
- 16,042 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002941:0
- 3,743 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002941:1
- 3,146 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002941:2
- 2,306 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002941:3
- 11,682 shares@ US$150.0118.6% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-002147:1
- 6,946 shares@ US$150.0011.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-002147:2
- 11,682 shares@ US$79.0221.8% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-002147:0
- 7,589 shares@ US$149.5426.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-001839:0
- 1,897 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001510:1
- 3,743 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001510:2
- 2,754 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001510:3
- 8,730 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001510:0
- 11,790 shares@ US$128.5122.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-21-011176:1
- 7,180 shares@ US$61.3610.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-21-011176:0
- 2,392 shares@ US$107.743.5% of flowCommon Stock, $0.01 par valueSEC:0001179110-21-002601:0
- 1,955 shares0Common Stock, $0.01 par valueSEC:0001179110-21-002042:0
- 574 shares0Common Stock, $0.01 par valueSEC:0001179110-21-002042:1
- 1,897 shares0Common Stock, $0.01 par valueSEC:0001179110-21-002042:2
- 3,743 shares0Common Stock, $0.01 par valueSEC:0001179110-21-002042:3
- 60 sharesCommon Stock, $0.01 par valueSEC:0001179110-20-005829:0
- 1,550 shares@ US$69.002.2% of flowCommon Stock, $0.01 par valueSEC:0001179110-20-005097:0Canonical exit: 18 Jun 2020 (T+90)
- 2,200 shares@ US$68.182.9% of flowCommon Stock, $0.01 par valueSEC:0001179110-20-004028:0Canonical exit: 16 Jun 2020 (T+90)
- 800 shares@ US$67.501.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-20-004028:1Canonical exit: 18 Jun 2020 (T+90)
- 750 shares@ US$69.001.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-20-004028:2Canonical exit: 18 Jun 2020 (T+90)
25 of 38 declarations
